Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

University of California San Diego

Also known as: UC San Diego, UCSanDiego, University of California, San Diego, UC San Diego Health, UC San Diego Center for Psychedelic Research, Psychedelics and Health Research Initiative, PHRI, University of California San Diego

Data updated

United States
7 Trials

The Psychedelics and Health Research Initiative (PHRI) focuses heavily on conducting pilot studies and clinical trials while collecting diverse biometric data—including fMRI, EEG, and cognitive metrics—from study participants. This data-driven approach aims to unravel the biological and neurological underpinnings of how psychedelics facilitate healing.

Academic Research

0 papers

Published Papers

0

Trial Involvement

7

Distinct Focus Topics

0

Latest Publication

Unknown

Government funding received

1 grant

NIDA — Non-classic psychedelics for methamphetamine use disorder

2024–2029

Five-year NIDA grant to a cross-disciplinary team led by Adam Halberstadt (UC San Diego) with the Medical College of Wisconsin. One of two non-clinical-trial grant applications selected by NIDA in this round. Focus: novel non-hallucinogenic psychedelic-derived compounds for methamphetamine use disorder.

Source

Ecosystem

1 connection

Philanthropic Funders

Steven & Alexandra Cohen Foundation

Clinical trial of psilocybin-assisted therapy for phantom limb pain

Jan 1, 2020

undisclosed

Psychedelics Research & Health Initiative - Steven & Alexandra Cohen Foundation

Quick Facts

Type
academic
HQ
United States
Website
Visit

Research Landscape

What the 7 registered trials University of California San Diego sponsors or participates in look like when you line them up. Counts come from Blossom’s trial records as of July 2026.

What's live right now, and what stopped?

Sourced

Registry status of all 7 University of California San Diego trials Blossom tracks. Orange marks trials recruiting or opening.

Recruiting or opening
457%
Completed
229%
Unknown / other
114%

Don't read stopped trials as failures: trials end early for funding, recruitment, and strategy reasons too. Status is as last synced from the registry; some 'recruiting' trials may already have finished.

Sponsored Trials

6

Collaborated Trials

1